PTC Therapeutics (PTCT) Earnings Date, Estimates & Call Transcripts → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free PTCT Stock Alerts $32.14 +3.57 (+12.50%) (As of 04/29/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (Apr. 25) -$1.20 Beat By $0.01 Consensus EPS (Apr. 25) -$1.21 Read Call TranscriptListen to Call Get PTC Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for PTCT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePTCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PTCT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. PTC Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($1.32)($0.87)($1.06) Q2 20243($1.85)($0.90)($1.38) Q3 20243($1.98)($0.76)($1.43) Q4 20243($2.09)($0.80)($1.49) FY 202412($7.24)($3.33)($5.37) Q1 20251($2.27)($2.27)($2.27) Q2 20251($2.62)($2.62)($2.62) Q3 20251($2.25)($2.25)($2.25) Q4 20251($2.02)($2.02)($2.02) FY 20254($9.16)($9.16) ($9.16)PTCT Earnings Date and InformationPTC Therapeutics last issued its quarterly earnings data on April 25th, 2024. The biopharmaceutical company reported ($1.20) earnings per share for the quarter, beating analysts' consensus estimates of ($1.21) by $0.01. The firm earned $210.12 million during the quarter, compared to analyst estimates of $160.27 million. PTC Therapeutics has generated ($7.68) earnings per share over the last year (($7.68) diluted earnings per share). Earnings for PTC Therapeutics are expected to grow in the coming year, from ($5.87) to ($5.17) per share. PTC Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More PTC Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024Estimated)------- 4/25/2024Q1 2024($1.21)($1.20)+$0.01($1.20)$160.27 million$210.12 million 2/29/2024Q4 2023$0.29($0.24)($0.53)$1.58$315.90 million$307.06 million10/26/2023Q3 2023($0.85)($1.76)($0.91)($1.76)$210.23 million$196.60 million 8/3/2023Q2 2023($1.58)($2.66)($1.08)($2.66)$206.99 million$213.80 million 4/27/2023Q1 2023($1.64)($1.88)($0.24)($1.88)$200.48 million$220.38 million 2/21/2023Q4 2022($1.96)($2.35)($0.39)($2.35)$183.07 million$167.41 million Get the Latest News and Ratings for PTCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PTC Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/27/2022Q3 2022($1.37)($1.53)($0.16)($1.53)$194.18 million$217.13 million8/4/2022Q2 2022($1.67)($2.13)($0.46)($2.13)$162.53 million$165.50 million 5/3/2022Q1 2022($1.55)($1.78)($0.23)($1.78)$146.90 million$148.74 million 2/22/2022Q4 2021($1.79)($2.03)($0.24)($2.03)$161.08 million$165.20 million 10/28/2021Q3 2021($1.78)($1.89)($0.11)($1.89)$118.87 million$139.00 million 7/29/2021Q2 2021($1.84)($1.68)+$0.16($1.68)$105.65 million$116.68 million 5/4/2021Q1 2021($1.59)($1.83)($0.24)($1.83)$98.77 million$117.94 million PTC Therapeutics Earnings - Frequently Asked Questions When is PTC Therapeutics's earnings date? PTC Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on PTCT's earnings history. Did PTC Therapeutics beat their earnings estimates last quarter? In the previous quarter, PTC Therapeutics (NASDAQ:PTCT) reported ($1.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.21) by $0.01. Learn more on analysts' earnings estimate vs. PTCT's actual earnings. How can I listen to PTC Therapeutics's earnings conference call? The conference call for PTC Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read PTC Therapeutics's conference call transcript? The conference call transcript for PTC Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does PTC Therapeutics generate each year? PTC Therapeutics (NASDAQ:PTCT) has a recorded annual revenue of $937.82 million. How much profit does PTC Therapeutics generate each year? PTC Therapeutics (NASDAQ:PTCT) has a recorded net income of -$626.60 million. PTCT has generated -$7.68 earnings per share over the last four quarters. What is PTC Therapeutics's EPS forecast for next year? PTC Therapeutics's earnings are expected to grow from ($5.87) per share to ($5.17) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MRVI Earnings Results GLPG Earnings Results GERN Earnings Results KROS Earnings Results AMPH Earnings Results RNA Earnings Results SDGR Earnings Results AGIO Earnings Results SNDX Earnings Results RCKT Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:PTCT) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PTC Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
